-
1
-
-
0001652380
-
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia
-
Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193-2194.
-
(2000)
Leukemia
, vol.14
, pp. 2193-2194
-
-
Schrappe, M.1
Camitta, B.2
Pui, C.H.3
Eden, T.4
Gaynon, P.5
Gustafsson, G.6
-
2
-
-
0347479243
-
International collaboration on childhood leukemia
-
Pui C-H, Ribeiro RC. International collaboration on childhood leukemia. Int J Hematol 2003; 78: 383-389.
-
(2003)
Int. J. Hematol.
, vol.78
, pp. 383-389
-
-
Pui, C.-H.1
Ribeiro, R.C.2
-
3
-
-
17744369251
-
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies 1982-1995
-
Conter V, Aricò M, Valsecchi MG, Basso G, Biondi A, Madon E et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia 2000; 14: 2196-2204.
-
(2000)
Leukemia
, vol.14
, pp. 2196-2204
-
-
Conter, V.1
Aricò, M.2
Valsecchi, M.G.3
Basso, G.4
Biondi, A.5
Madon, E.6
-
4
-
-
0034517924
-
Long-term results of four consecutives trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
-
Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G et al. Long-term results of four consecutives trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000; 14: 2205-2222.
-
(2000)
Leukemia
, vol.14
, pp. 2205-2222
-
-
Schrappe, M.1
Reiter, A.2
Zimmermann, M.3
Harbott, J.4
Ludwig, W.D.5
Henze, G.6
-
5
-
-
0034525989
-
Children's Cancer Group trials in childhood acute lymphoblastic leukemia 1983-1995
-
Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000; 14: 2223-2233.
-
(2000)
Leukemia
, vol.14
, pp. 2223-2233
-
-
Gaynon, P.S.1
Trigg, M.E.2
Heerema, N.A.3
Sensel, M.G.4
Sather, H.N.5
Hammond, G.D.6
-
6
-
-
0034523201
-
Co-operative study group for childhood acute lymphoblastic leukemia (COALL): Long-term follow-up of trials 82 85 89 and 92
-
Harms DO, Janka-Schaub GE. Co-operative study group for childhood acute lymphoblastic leukemia (COALL); long-term follow-up of trials 82, 85, 89 and 92. Leukemia 2000; 14: 2234-2239.
-
(2000)
Leukemia
, vol.14
, pp. 2234-2239
-
-
Harms, D.O.1
Janka-Schaub, G.E.2
-
7
-
-
0034518867
-
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia 1984-1991
-
Kamps WA, Veerman AJ, van Wering ER, van Weerden JF, Slater R, van der Does-van den Berg A. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991. Leukemia 2000; 14: 2240-2246.
-
(2000)
Leukemia
, vol.14
, pp. 2240-2246
-
-
Kamps, W.A.1
Veerman, A.J.2
van Wering, E.R.3
van Weerden, J.F.4
Slater, R.5
van der Does-van den Berg, A.6
-
8
-
-
17744380400
-
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)
-
Silverman LB, Declerck L, Gelber RD, Kimball Dalton V, Asselin BL, Barr RD et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 2000; 14: 2247-2256.
-
(2000)
Leukemia
, vol.14
, pp. 2247-2256
-
-
Silverman, L.B.1
Declerck, L.2
Gelber, R.D.3
Kimball Dalton, V.4
Asselin, B.L.5
Barr, R.D.6
-
9
-
-
17744400282
-
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphohlastic leukemia: A CLCG-EORTC report
-
Vilmer E, Suciu S, Ferster A, Bertrand Y, Cave H, Thyss A et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphohlastic leukemia: a CLCG-EORTC report. Leukemia 2000; 14: 2257-2266.
-
(2000)
Leukemia
, vol.14
, pp. 2257-2266
-
-
Vilmer, E.1
Suciu, S.2
Ferster, A.3
Bertrand, Y.4
Cave, H.5
Thyss, A.6
-
10
-
-
0038185593
-
Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation
-
Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000; 14: 2267-2275.
-
(2000)
Leukemia
, vol.14
, pp. 2267-2275
-
-
Gustafsson, G.1
Schmiegelow, K.2
Forestier, E.3
Clausen, N.4
Glomstein, A.5
Jonmundsson, G.6
-
11
-
-
0034525194
-
Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994
-
Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia 2000; 14: 2276-2285.
-
(2000)
Leukemia
, vol.14
, pp. 2276-2285
-
-
Maloney, K.W.1
Shuster, J.J.2
Murphy, S.3
Pullen, J.4
Camitta, B.A.5
-
12
-
-
17744383161
-
Long-term results of Total Therapy studies 11 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
-
Pui C-H, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000; 14: 2286-2294.
-
(2000)
Leukemia
, vol.14
, pp. 2286-2294
-
-
Pui, C.-H.1
Boyett, J.M.2
Rivera, G.K.3
Hancock, M.L.4
Sandlund, J.T.5
Ribeiro, R.C.6
-
13
-
-
17744373053
-
Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995
-
Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K et al. Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995. Leukemia 2000; 14: 2295-2306.
-
(2000)
Leukemia
, vol.14
, pp. 2295-2306
-
-
Tsuchida, M.1
Ikuta, K.2
Hanada, R.3
Saito, T.4
Isoyama, K.5
Sugita, K.6
-
14
-
-
0034525991
-
Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia 1980-1997
-
Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia 2000; 14: 2307-2320.
-
(2000)
Leukemia
, vol.14
, pp. 2307-2320
-
-
Eden, O.B.1
Harrison, G.2
Richards, S.3
Lilleyman, J.S.4
Bailey, C.C.5
Chessells, J.M.6
-
15
-
-
0034611661
-
Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
-
Aricò M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998-1006.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 998-1006
-
-
Aricò, M.1
Valsecchi, M.G.2
Camitta, B.3
Schrappe, M.4
Chessells, J.5
Baruchel, A.6
-
16
-
-
2942725639
-
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are non-random and may be associated with outcome
-
Heerema NA, Harbott J, Galimberti S, Valsecchi MG, Camitta BM, Gaynon PS et al. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are non-random and may be associated with outcome. Leukemia, 2004; 18: 693-702.
-
(2004)
Leukemia
, vol.18
, pp. 693-702
-
-
Heerema, N.A.1
Harbott, J.2
Galimberti, S.3
Valsecchi, M.G.4
Camitta, B.M.5
Gaynon, P.S.6
-
17
-
-
0036606506
-
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
-
Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909-1915.
-
(2002)
Lancet
, vol.359
, pp. 1909-1915
-
-
Pui, C.H.1
Gaynon, P.S.2
Boyett, J.M.3
Chessells, J.M.4
Baruchel, A.5
Kamps, W.6
-
18
-
-
0242500374
-
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
-
Pui CH, Chessell JM, Camitta B, Baruchel A, Biondi A, Boyett JM et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17: 700-706.
-
(2003)
Leukemia
, vol.17
, pp. 700-706
-
-
Pui, C.H.1
Chessell, J.M.2
Camitta, B.3
Baruchel, A.4
Biondi, A.5
Boyett, J.M.6
-
19
-
-
0031853410
-
Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997
-
Pui CH, Evans WE, Gilbert JR. Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997. Leukemia 1998; 12: 1313-1318.
-
(1998)
Leukemia
, vol.12
, pp. 1313-1318
-
-
Pui, C.H.1
Evans, W.E.2
Gilbert, J.R.3
-
20
-
-
0035001835
-
International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito CA 30 November-1 December 2000
-
Pui CH, Sallan S, Relling MV, Masera G, Evans WE. International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia 2001; 15: 707-715.
-
(2001)
Leukemia
, vol.15
, pp. 707-715
-
-
Pui, C.H.1
Sallan, S.2
Relling, M.V.3
Masera, G.4
Evans, W.E.5
-
21
-
-
0037399325
-
'Ponte di Legno' Working Group - Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna Austria 9 April-May 2002
-
Gadner H, Haas OA, Masera G, Pui CH, Schrappe M. 'Ponte di Legno' Working Group - report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 9 April-May 2002. Leukemia 2003; 17: 798-803.
-
(2003)
Leukemia
, vol.17
, pp. 798-803
-
-
Gadner, H.1
Haas, O.A.2
Masera, G.3
Pui, C.H.4
Schrappe, M.5
-
22
-
-
0035810142
-
Acitivity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
-
Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Acitivity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038-1042.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1038-1042
-
-
Druker, B.J.1
Sawyers, C.L.2
Kantarjian, H.3
Resta, D.J.4
Reese, S.F.5
Ford, J.M.6
-
23
-
-
0037105560
-
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
-
Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965-1971.
-
(2002)
Blood
, vol.100
, pp. 1965-1971
-
-
Ottmann, O.G.1
Druker, B.J.2
Sawyers, C.L.3
Goldman, J.M.4
Reiffers, J.5
Silver, R.T.6
-
24
-
-
0037220339
-
Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)
-
Scheuring UJ, Pfeifer H, Wassmann B, Brück P, Atta J, Petershofen EK et al. Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 2003; 101: 85-90.
-
(2003)
Blood
, vol.101
, pp. 85-90
-
-
Scheuring, U.J.1
Pfeifer, H.2
Wassmann, B.3
Brück, P.4
Atta, J.5
Petershofen, E.K.6
-
25
-
-
0036940238
-
Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
-
Wassmann B, Pfeifer H, Scheuring U, Klein SA, Gökbuget N, Binckebanck A et al. Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL). Leukemia 2002; 16: 2358-2365.
-
(2002)
Leukemia
, vol.16
, pp. 2358-2365
-
-
Wassmann, B.1
Pfeifer, H.2
Scheuring, U.3
Klein, S.A.4
Gökbuget, N.5
Binckebanck, A.6
-
26
-
-
0142151254
-
Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-α (IFN-α) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)
-
Wassmann B, Scheuring U, Pfeifer H, Binckebanck A, Käbisch A, Lübbert M et al. Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-α (IFN-α) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Leukemia 2003; 17: 1919-1924.
-
(2003)
Leukemia
, vol.17
, pp. 1919-1924
-
-
Wassmann, B.1
Scheuring, U.2
Pfeifer, H.3
Binckebanck, A.4
Käbisch, A.5
Lübbert, M.6
-
27
-
-
0141958270
-
Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
-
Lee S, Kim DW, Kim YJ, Chung NG, Kim YL, Hwang JY et al. Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 2003; 102: 3068-3070.
-
(2003)
Blood
, vol.102
, pp. 3068-3070
-
-
Lee, S.1
Kim, D.W.2
Kim, Y.J.3
Chung, N.G.4
Kim, Y.L.5
Hwang, J.Y.6
-
28
-
-
0344089318
-
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias
-
Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A et al. Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias. Leukemia 2003; 17: 290-297.
-
(2003)
Leukemia
, vol.17
, pp. 290-297
-
-
Shimoni, A.1
Kröger, N.2
Zander, A.R.3
Rowe, J.M.4
Hardan, I.5
Avigdor, A.6
-
29
-
-
0032532289
-
+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
-
+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730-2741.
-
(1998)
Blood
, vol.92
, pp. 2730-2741
-
-
Schrappe, M.1
Aricò, M.2
Harbott, J.3
Biondi, A.4
Zimmermann, M.5
Conter, V.6
-
31
-
-
0030870639
-
Philadelphia chromosome-positive acute lymphoblastic leukemia in children: Durable responses to chemotherapy associated with low initial white blood cell counts
-
Ribeiro RC, Broniscer A, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia 1997; 11: 1493-1496.
-
(1997)
Leukemia
, vol.11
, pp. 1493-1496
-
-
Ribeiro, R.C.1
Broniscer, A.2
Rivera, G.K.3
Hancock, M.L.4
Raimondi, S.C.5
Sandlund, J.T.6
-
32
-
-
0037045589
-
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: A gene-expression study
-
Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet 2002; 359: 481-486.
-
(2002)
Lancet
, vol.359
, pp. 481-486
-
-
Hofmann, W.K.1
de Vos, S.2
Elashoff, D.3
Gschaidmeier, H.4
Hoelzer, D.5
Koeffler, H.P.6
-
33
-
-
10744224144
-
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia
-
Scrideli CA, Cazzaniga G, Fazio G, Pirola L, Callegaro A, Bassan R et al. Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia 2003; 17: 2234-2237.
-
(2003)
Leukemia
, vol.17
, pp. 2234-2237
-
-
Scrideli, C.A.1
Cazzaniga, G.2
Fazio, G.3
Pirola, L.4
Callegaro, A.5
Bassan, R.6
-
34
-
-
1642541155
-
Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia
-
Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004; 103: 1043-1049.
-
(2004)
Blood
, vol.103
, pp. 1043-1049
-
-
Fine, B.M.1
Stanulla, M.2
Schrappe, M.3
Ho, M.4
Viehmann, S.5
Harbott, J.6
-
35
-
-
0034235115
-
Biological and therapeutic aspects of infant leukemia
-
Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24-33.
-
(2000)
Blood
, vol.96
, pp. 24-33
-
-
Biondi, A.1
Cimino, G.2
Pieters, R.3
Pui, C.H.4
-
36
-
-
18444409012
-
Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance
-
Ramakers-van Woerden NL, Pieters R, Rots MG, van Zantwijk CH, Noordhuis P, Beverloo HB et al. Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance. Leukemia 2002; 16: 949-951.
-
(2002)
Leukemia
, vol.16
, pp. 949-951
-
-
Ramakers-van Woerden, N.L.1
Pieters, R.2
Rots, M.G.3
van Zantwijk, C.H.4
Noordhuis, P.5
Beverloo, H.B.6
-
37
-
-
0003216377
-
High risk infant ALL-improved survival with intensive chemotherapy
-
Dreyer ZE, Steuber CP, Bowman WP, Murray JC, Coppes MJ, Dinndorf P et al. High risk infant ALL-improved survival with intensive chemotherapy. Proc Am Soc Clin Oncol 1998; 17: 529a.
-
(1998)
Proc. Am. Soc. Clin. Oncol.
, vol.17
, pp. 529
-
-
Dreyer, Z.E.1
Steuber, C.P.2
Bowman, W.P.3
Murray, J.C.4
Coppes, M.J.5
Dinndorf, P.6
-
38
-
-
19044399684
-
Classification subtype discovery and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
-
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
-
(2002)
Cancer Cell
, vol.1
, pp. 133-143
-
-
Yeoh, E.J.1
Ross, M.E.2
Shurtleff, S.A.3
Williams, W.K.4
Patel, D.5
Mahfouz, R.6
-
39
-
-
18544375333
-
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
-
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
-
(2002)
Nat. Genet.
, vol.30
, pp. 41-47
-
-
Armstrong, S.A.1
Staunton, J.E.2
Silverman, L.B.3
Pieters, R.4
den Boer, M.L.5
Minden, M.D.6
-
40
-
-
17144474314
-
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
-
Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
-
(2002)
Cancer Cell
, vol.1
, pp. 75-87
-
-
Ferrando, A.A.1
Neuberg, D.S.2
Staunton, J.3
Loh, M.L.4
Huard, C.5
Raimondi, S.C.6
-
41
-
-
0037738513
-
Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells
-
(erratum in Nat Genet 2003; 34: 231)
-
Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 2003; 34: 85-90, (erratum in Nat Genet 2003; 34: 231).
-
(2003)
Nat. Genet.
, vol.34
, pp. 85-90
-
-
Cheok, M.H.1
Yang, W.2
Pui, C.H.3
Downing, J.R.4
Cheng, C.5
Naeve, C.W.6
-
42
-
-
0013312329
-
Inhibition of FLT3 in MLL Validation of a therapeutic target identification by gene expression based classification
-
Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, den Boer ML et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identification by gene expression based classification. Cancer Cell 2003; 3: 173-183.
-
(2003)
Cancer Cell
, vol.3
, pp. 173-183
-
-
Armstrong, S.A.1
Kung, A.L.2
Mabon, M.E.3
Silverman, L.B.4
Stam, R.W.5
den Boer, M.L.6
-
43
-
-
0038103843
-
DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: Choice of technique and purification influence the identification of potential diagnostic markers
-
Staal FJT, van der Burg M, Wessels LFA, Barendregt BH, Baert MRM, van den Burg CMM et al. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia 2003; 17: 1324-1332.
-
(2003)
Leukemia
, vol.17
, pp. 1324-1332
-
-
Staal, F.J.T.1
van der Burg, M.2
Wessels, L.F.A.3
Barendregt, B.H.4
Baert, M.R.M.5
van den Burg, C.M.M.6
-
44
-
-
0742289562
-
Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients
-
Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 2004; 18: 63-71.
-
(2004)
Leukemia
, vol.18
, pp. 63-71
-
-
Kohlmann, A.1
Schoch, C.2
Schnittger, S.3
Dugas, M.4
Hiddemann, W.5
Kern, W.6
-
45
-
-
0025234883
-
Clinical presentation, karyotypic characterization and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid <45 line
-
Pui CH, Carroll AJ, Raimondi SC, Land VJ, Crist WM, Shuster JJ et al. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid <45 line. Blood 1990; 75: 1170-1177.
-
(1990)
Blood
, vol.75
, pp. 1170-1177
-
-
Pui, C.H.1
Carroll, A.J.2
Raimondi, S.C.3
Land, V.J.4
Crist, W.M.5
Shuster, J.J.6
-
46
-
-
13044264463
-
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
-
Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1999; 94: 4036-4045.
-
(1999)
Blood
, vol.94
, pp. 4036-4045
-
-
Heerema, N.A.1
Nachman, J.B.2
Sather, H.N.3
Sensel, M.G.4
Lee, M.K.5
Hutchinson, R.6
-
47
-
-
85014143894
-
AML1 gene over-expression in childhood acute lymphoblastic leukemia
-
Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM et al. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 2002; 16: 658-668.
-
(2002)
Leukemia
, vol.16
, pp. 658-668
-
-
Mikhail, F.M.1
Serry, K.A.2
Hatem, N.3
Mourad, Z.I.4
Farawela, H.M.5
El Kaffash, D.M.6
-
48
-
-
0037348975
-
Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: A study of 20 cases
-
Harewood L, Robinson H, Harris R, Jabbar Al-Obaidi M, Jalali GR, Martineau M et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 2003; 17: 547-553.
-
(2003)
Leukemia
, vol.17
, pp. 547-553
-
-
Harewood, L.1
Robinson, H.2
Harris, R.3
Jabbar Al-Obaidi, M.4
Jalali, G.R.5
Martineau, M.6
-
49
-
-
10744223283
-
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome
-
Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 2003; 17: 2249-2250.
-
(2003)
Leukemia
, vol.17
, pp. 2249-2250
-
-
Robinson, H.M.1
Broadfield, Z.J.2
Cheung, K.L.3
Harewood, L.4
Harris, R.L.5
Jalali, G.R.6
-
51
-
-
0034210549
-
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90
-
Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95: 3310-3322.
-
(2000)
Blood
, vol.95
, pp. 3310-3322
-
-
Schrappe, M.1
Reiter, A.2
Ludwig, W.D.3
Harbott, J.4
Zimmermann, M.5
Hiddemann, W.6
-
52
-
-
0142024750
-
Results of therapy for acute lymphoblastic leukemia in black and white children
-
Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003; 290: 2001-2007.
-
(2003)
JAMA
, vol.290
, pp. 2001-2007
-
-
Pui, C.H.1
Sandlund, J.T.2
Pei, D.3
Rivera, G.K.4
Howard, S.C.5
Ribeiro, R.C.6
-
53
-
-
2542484729
-
Recent advances in childhood acute lymphoblastic leukemia
-
(in press)
-
Pui CH. Recent advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc, (in press).
-
J. Formos. Med. Assoc.
-
-
Pui, C.H.1
-
54
-
-
0026716252
-
Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia
-
Secker-Walker LM, Berger R, Fenaux P, Lai JL, Nelken B, Garson M et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992; 6: 363-369.
-
(1992)
Leukemia
, vol.6
, pp. 363-369
-
-
Secker-Walker, L.M.1
Berger, R.2
Fenaux, P.3
Lai, J.L.4
Nelken, B.5
Garson, M.6
-
55
-
-
0027961005
-
Immunologic, cytogenetic and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative
-
Pui CH, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH et al. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 1994; 12: 2601-2606.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 2601-2606
-
-
Pui, C.H.1
Raimondi, S.C.2
Hancock, M.L.3
Rivera, G.K.4
Ribeiro, R.C.5
Mahmoud, H.H.6
-
56
-
-
0031918423
-
Clinical significance of translocation t(1;19) in childhood acute lymphohlastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group
-
Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ et al. Clinical significance of translocation t(1;19) in childhood acute lymphohlastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527-535.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 527-535
-
-
Uckun, F.M.1
Sensel, M.G.2
Sather, H.N.3
Gaynon, P.S.4
Arthur, D.C.5
Lange, B.J.6
-
57
-
-
0141634051
-
Origins of chromosome translocations in childhood leukaemia
-
Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639-649.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 639-649
-
-
Greaves, M.F.1
Wiemels, J.2
-
58
-
-
18744372705
-
Site-specific translocation and evidence of post-natal origin of the t(1;19) E2A-PBX1 translocation in childhood acute lymphoblastic leukemia
-
Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith MT et al. Site-specific translocation and evidence of post-natal origin of the t(1;19) E2A-PBX1 translocation in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2002; 99: 15101-15106.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 15101-15106
-
-
Wiemels, J.L.1
Leonard, B.C.2
Wang, Y.3
Segal, M.R.4
Hunger, S.P.5
Smith, M.T.6
-
59
-
-
0036014993
-
TEL/AML1-positive pediatric leukemia: Prognostic significance and therapeutic approaches
-
Loh ML, Rubnitz JE. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 2002; 9: 345-352.
-
(2002)
Curr. Opin. Hematol.
, vol.9
, pp. 345-352
-
-
Loh, M.L.1
Rubnitz, J.E.2
-
60
-
-
0035411192
-
Minimal residual disease in leukaemia patients
-
Szczepañski T, Orfão A, van der Velden VHJ, San Miguel JF, van Dongen JJM. Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409-417.
-
(2001)
Lancet Oncol.
, vol.2
, pp. 409-417
-
-
Szczepañski, T.1
Orfão, A.2
van der Velden, V.H.J.3
San Miguel, J.F.4
van Dongen, J.J.M.5
-
61
-
-
0035473994
-
Childhood acute lymphoblastic leukaemia - Current status and future perspectives
-
Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol 2001; 2: 597-607.
-
(2001)
Lancet Oncol.
, vol.2
, pp. 597-607
-
-
Pui, C.H.1
Campana, D.2
Evans, W.E.3
-
62
-
-
0042026876
-
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: Relation to other risk factors A Children's Oncology Group study
-
Borowitz MJ, Pullen DJ, Shuster JJ, Viswanatha D, Montgomery K, Willman CL et al. Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. Leukemia 2003; 17: 1566-1572.
-
(2003)
Leukemia
, vol.17
, pp. 1566-1572
-
-
Borowitz, M.J.1
Pullen, D.J.2
Shuster, J.J.3
Viswanatha, D.4
Montgomery, K.5
Willman, C.L.6
-
63
-
-
0037866469
-
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: Evidence for the persistence of a preleukemic clone
-
Konrad M, Metzler M, Panzer S, Streicher I, Peham M, Repp R et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 2003; 101: 3635-3640.
-
(2003)
Blood
, vol.101
, pp. 3635-3640
-
-
Konrad, M.1
Metzler, M.2
Panzer, S.3
Streicher, I.4
Peham, M.5
Repp, R.6
-
64
-
-
0026769756
-
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study
-
Harris MB, Shuster JJ, Carroll A, Look AT, Borowitz MJ, Crist WM et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992; 79: 3316-3324.
-
(1992)
Blood
, vol.79
, pp. 3316-3324
-
-
Harris, M.B.1
Shuster, J.J.2
Carroll, A.3
Look, A.T.4
Borowitz, M.J.5
Crist, W.M.6
-
65
-
-
17444441536
-
Prognostic impact of trisomies of chromosomes 10 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)
-
Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). J Clin Oncol 2000; 18: 1876-1887.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 1876-1887
-
-
Heerema, N.A.1
Sather, H.N.2
Sensel, M.G.3
Zhang, T.4
Hutchinson, R.J.5
Nachman, J.B.6
-
66
-
-
0035021732
-
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
-
(erratum in Br J Haematol 2001; 113: 844; Br J Haematol 2001; 114: 738)
-
Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001; 113: 103-114, (erratum in Br J Haematol 2001; 113: 844; Br J Haematol 2001; 114: 738).
-
(2001)
Br. J. Haematol.
, vol.113
, pp. 103-114
-
-
Hann, I.1
Vora, A.2
Harrison, G.3
Harrison, C.4
Eden, O.5
Hill, F.6
-
67
-
-
0141923915
-
Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia
-
Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood 2003; 102: 2756-2762.
-
(2003)
Blood
, vol.102
, pp. 2756-2762
-
-
Moorman, A.V.1
Richards, S.M.2
Martineau, M.3
Cheung, K.L.4
Robinson, H.M.5
Jalali, G.R.6
-
68
-
-
0028823480
-
Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukaemia
-
Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM et al. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukaemia. Leukemia 1995; 9: 1726-1734.
-
(1995)
Leukemia
, vol.9
, pp. 1726-1734
-
-
Steenbergen, E.J.1
Verhagen, O.J.2
van Leeuwen, E.F.3
van den Berg, H.4
Behrendt, H.5
Slater, R.M.6
-
69
-
-
0035856232
-
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
-
Eckert C, Biondi A, Seeger K, Cazzaniga G, Hartmann R, Beyermann B et al. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet 2001; 358: 1239-1241.
-
(2001)
Lancet
, vol.358
, pp. 1239-1241
-
-
Eckert, C.1
Biondi, A.2
Seeger, K.3
Cazzaniga, G.4
Hartmann, R.5
Beyermann, B.6
-
70
-
-
1542503795
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse
-
Coustan-Smith E, Gajjar A, Hijiya N, Razzouk BI, Ribeiro RC, Rivera GK et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia 2004; 18: 499-504.
-
(2004)
Leukemia
, vol.18
, pp. 499-504
-
-
Coustan-Smith, E.1
Gajjar, A.2
Hijiya, N.3
Razzouk, B.I.4
Ribeiro, R.C.5
Rivera, G.K.6
-
72
-
-
0032400846
-
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
-
Knechtli CJ, Goulden NJ, Hancock JP, Grandage VL, Harris EL, Garland RJ et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92: 4072-4079.
-
(1998)
Blood
, vol.92
, pp. 4072-4079
-
-
Knechtli, C.J.1
Goulden, N.J.2
Hancock, J.P.3
Grandage, V.L.4
Harris, E.L.5
Garland, R.J.6
-
73
-
-
0034857383
-
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia
-
van der Velden VH, Joosten SA, Willemse MJ, van Wering ER, Lankester AW, van Dongen JJ et al. Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia. Leukemia 2001; 15: 1485-1487.
-
(2001)
Leukemia
, vol.15
, pp. 1485-1487
-
-
van der Velden, V.H.1
Joosten, S.A.2
Willemse, M.J.3
van Wering, E.R.4
Lankester, A.W.5
van Dongen, J.J.6
-
74
-
-
0036736498
-
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
-
Bader P, Hancock J, Kreyenberg H, Goulden NJ, Niethammer D, Oakhill A et al. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002; 16: 1668-1672.
-
(2002)
Leukemia
, vol.16
, pp. 1668-1672
-
-
Bader, P.1
Hancock, J.2
Kreyenberg, H.3
Goulden, N.J.4
Niethammer, D.5
Oakhill, A.6
-
75
-
-
0038007444
-
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia
-
Goulden N, Bader P, Van der Velden V, Moppett J, Schilham M, Masden HO et al. Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia. Br J Haematol 2003; 122: 24-29.
-
(2003)
Br. J. Haematol.
, vol.122
, pp. 24-29
-
-
Goulden, N.1
Bader, P.2
Van der Velden, V.3
Moppett, J.4
Schilham, M.5
Masden, H.O.6
-
76
-
-
0347994940
-
Determinants of antileukemia effects of allogeneic NK cells
-
Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644-650.
-
(2004)
J. Immunol.
, vol.172
, pp. 644-650
-
-
Leung, W.1
Iyengar, R.2
Turner, V.3
Lang, P.4
Bader, P.5
Conn, P.6
-
77
-
-
0034075711
-
The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: A report on the Medical Research Council UKALLR1 study
-
Lawson SE, Harrison G, Richards S, Oakhill A, Stevens R, Eden OB et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study. Br J Haematol 2000; 108: 531-543.
-
(2000)
Br. J. Haematol.
, vol.108
, pp. 531-543
-
-
Lawson, S.E.1
Harrison, G.2
Richards, S.3
Oakhill, A.4
Stevens, R.5
Eden, O.B.6
-
78
-
-
0033807095
-
Comparison of allogeneic transplant vs chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
-
MRC Childhood Leukaemia Working Party
-
Harrison G, Richards S, Lawson S, Darbyshire P, Pinkerton R, Stevens R et al. Comparison of allogeneic transplant vs chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party. Ann Oncol 2000; 11: 999-1006.
-
(2000)
Ann. Oncol.
, vol.11
, pp. 999-1006
-
-
Harrison, G.1
Richards, S.2
Lawson, S.3
Darbyshire, P.4
Pinkerton, R.5
Stevens, R.6
-
79
-
-
0034284267
-
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: A Pediatric Oncology Group Study
-
Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 2000; 96: 1709-1715.
-
(2000)
Blood
, vol.96
, pp. 1709-1715
-
-
Abshire, T.C.1
Pollock, B.H.2
Billett, A.L.3
Bradley, P.4
Buchanan, G.R.5
-
80
-
-
12444270688
-
Epratuzumab a humanized monoclonal antibody targeting CD22: Characterization of in vitro properties
-
Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T et al. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Clin Cancer Res 2003; 9: 3982S-3990S.
-
(2003)
Clin. Cancer Res.
, vol.9
-
-
Carnahan, J.1
Wang, P.2
Kendall, R.3
Chen, C.4
Hu, S.5
Boone, T.6
-
81
-
-
0036182540
-
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)
-
Leonard JP, Link BK. Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab). Semin Oncol 2002; 29 (1 Suppl. 2):81-86.
-
(2002)
Semin. Oncol.
, vol.29
, Issue.1 SUPPL. 2
, pp. 81-86
-
-
Leonard, J.P.1
Link, B.K.2
-
82
-
-
2942677283
-
Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia
-
[Epub ahead of print] April 1
-
Hak LJ, Relling MV, Cheng C, Pei D, Wang B, Sandlund JT et al. Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia. Leukemia, [Epub ahead of print] April 1, 2004.
-
(2004)
Leukemia
-
-
Hak, L.J.1
Relling, M.V.2
Cheng, C.3
Pei, D.4
Wang, B.5
Sandlund, J.T.6
-
83
-
-
0142062911
-
MLL-rearranged leukemias: Insights from gene expression profiling
-
Armstrong SA, Golub TR, Korsmeyer SJ. MLL-rearranged leukemias: insights from gene expression profiling. Semin Hematol 2003; 40: 268-273.
-
(2003)
Semin. Hematol.
, vol.40
, pp. 268-273
-
-
Armstrong, S.A.1
Golub, T.R.2
Korsmeyer, S.J.3
-
84
-
-
0141836914
-
FLT3: It does matter in leukemia
-
Levis M, Small D. FLT3: it does matter in leukemia. Leukemia 2003; 17: 1738-1752.
-
(2003)
Leukemia
, vol.17
, pp. 1738-1752
-
-
Levis, M.1
Small, D.2
-
85
-
-
0035448564
-
Cancer in siblings of children with cancer in the Nordic countries: A population-based cohort study
-
Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L et al. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet 2001; 358: 711-717.
-
(2001)
Lancet
, vol.358
, pp. 711-717
-
-
Winther, J.F.1
Sankila, R.2
Boice, J.D.3
Tulinius, H.4
Bautz, A.5
Barlow, L.6
|